Empowered Funds LLC Boosts Stock Holdings in Select Medical Holdings Corporation $SEM

Key Points

• Empowered Funds LLC increased its stake in Select Medical Holdings Corporation by 96.0% during the 1st quarter, now owning 613,801 shares worth approximately $10.25 million.
• Select Medical reported $0.32 earnings per share for the latest quarter, surpassing expectations, with a revenue of $1.34 billion for the period.
• The stock has a current market cap of $1.60 billion and is down 2.4% recently, with a consensus average target price of $20.25 from analysts.

Empowered Funds LLC grew its stake in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 96.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 613,801 shares of the health services provider's stock after purchasing an additional 300,631 shares during the quarter. Empowered Funds LLC owned approximately 0.48% of Select Medical worth $10,250,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of SEM. Bank of America Corp DE increased its position in shares of Select Medical by 46.7% during the fourth quarter. Bank of America Corp DE now owns 1,192,578 shares of the health services provider's stock worth $22,480,000 after acquiring an additional 379,598 shares during the period. Deutsche Bank AG increased its position in shares of Select Medical by 47.4% during the fourth quarter. Deutsche Bank AG now owns 93,316 shares of the health services provider's stock worth $1,759,000 after acquiring an additional 30,023 shares during the period. D. E. Shaw & Co. Inc. lifted its stake in Select Medical by 5.3% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 49,330 shares of the health services provider's stock worth $930,000 after acquiring an additional 2,469 shares during the period. Graham Capital Management L.P. purchased a new stake in Select Medical in the fourth quarter worth about $1,125,000. Finally, Lazard Asset Management LLC lifted its stake in Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock worth $130,000 after acquiring an additional 2,255 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Performance

Shares of Select Medical stock traded down $0.12 during midday trading on Monday, hitting $12.40. The company had a trading volume of 164,996 shares, compared to its average volume of 1,114,724. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $40.98. The company has a fifty day simple moving average of $13.41 and a 200 day simple moving average of $15.08. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of 11.69, a PEG ratio of 0.51 and a beta of 1.25.

Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, July 31st. The health services provider reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The firm had revenue of $1.34 billion during the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter last year, the company posted $0.60 earnings per share. The firm's revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Wednesday, August 13th were issued a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend was Wednesday, August 13th. Select Medical's dividend payout ratio (DPR) is 23.58%.

Analyst Ratings Changes

SEM has been the subject of a number of research reports. Bank of America lowered their price objective on shares of Select Medical from $18.00 to $15.00 and set a "buy" rating for the company in a research note on Wednesday, September 10th. UBS Group restated a "neutral" rating and issued a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $19.20.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.